Geron Corporation Stock Analysis & AI Score
Geron Corporation (GERN) has an ST Score of 57.2 (B-), driven by its Growth (A) and held back by its Financial Strength (C-). Analysts rate it Buy with a $5.89 price target (+367.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Geron Corporation (GERN) has an ST Score of 57.2 (B-), driven by its Growth (A) and held back by its Financial Strength (C-). Analysts rate it Buy with a $5.89 price target (+367.5% upside).
- Strongest
- GrowthA
- Weakest
- Financial StrengthC-
All factor grades
- GrowthA
- ForecastA
- ProfitabilityA-
- ValuationB-
- MomentumC
- Financial StrengthC-
- Piotroski1/9
Contact
GERN stock: frequently asked questions
What is GERN's ST Score?
Geron Corporation (GERN) has an ST Score of 57.2 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is GERN a buy, hold, or sell?
Analysts rate GERN a Buy, with a price target of $5.89 (+367.5% vs the current price). Our ST Score grades it B- (57.2/100). The ST Score is a data-driven signal, not a recommendation.
What are GERN's factor grades?
Valuation B-, Profitability A-, Financial Strength C-, Momentum C, Growth A, Forecast A.
What is GERN's valuation grade?
Geron Corporation (GERN) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is GERN's growth grade?
Geron Corporation (GERN) earns a growth grade of A, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is GERN's profitability grade?
Geron Corporation (GERN) earns a profitability grade of A-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is GERN's financial strength grade?
Geron Corporation (GERN) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for GERN?
The average analyst price target for Geron Corporation (GERN) is $5.89 from 22 analysts, which is +367.5% versus the recent price of $1.26.
What is GERN's Piotroski score?
Geron Corporation (GERN) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.